On May 5, 2020 Moberg Pharma AB (OMX: MOB) reported that it will present its Interim report for July 2019 – March 2020. Investors, analysts and journalists are hereby invited to participate in a teleconference at 3:00 pm (CET) on the same date (Press release, Moberg Pharma, MAY 5, 2020, View Source;march-2020-to-be-published-on-may-12—invitation-to-teleconference-301052617.html [SID1234557065]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The teleconference will be hosted by Moberg Pharmas’s CEO Anna Ljung and VP Finance Mark Beveridge. The presentation will be held in English.
Date: May 12th, 2020
Time: 3:00 pm (CET)
To participate in the conference, please dial in on any number below before the start of the call:
SE: +46 8 505 583 69
US: +1 833 249 84 04
The quarterly report and other information material will be made public on:
View Source